Comparison of clinical outcomes between 1st-line osimertinib, 1G/2G EGFR-TKIs followed by osimertinib and without osimertinib-MedSci.cn - 梅斯（MedSci）

Comparison of clinical outcomes between 1st-line osimertinib, 1G/2G EGFR-TKIs followed by osimertinib and without osimertinib

Uehara, Y; Yoshida, T; Takeyasu, Y; Tateichi, A; Torasawa, M; Masuda, K; Shinno, Y; Matsumoto, Y; Okuma, Y; Goto, Y; Horinouchi, H; Yamamoto, N; Ohe, Y

ANNALS OF ONCOLOGY, 2023; 34 (): S1418

科室
- - 订阅+
  - 更多科室
工具
服务